Safety and Efficacy of Propionyl-L-Carnitine in the Treatment of Peripheral Arterial Disease (Intermittent Claudication)
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
Patients with peripheral artery disease have decreased blood flow to exercising muscle
causing pain. This decreased blood flow to the muscle affects the level of acylcarnitines
which in turn decreases the level of carnitine. Carnitine allows muscles to function
properly. This study will test the safety and efficacy of Propionyl-L-Carnitine taken in
combination with a monitored exercise training program.